Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 75.5 | 64 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 63.5 | 64 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 80.0 | 85 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 95.5 | 66 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 93.0 | 54 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 38.5 | 60 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 44.5 | 64 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 38.0 | 65 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 34.0 | 81 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 36.5 | 68 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 35.0 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 55.5 | 68 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 67.0 | 37 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 49.0 | 60 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 66.0 | 53 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 68.5 | 58 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | IL-17 | 84.0 | 54 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-17 | 33.0 | 61 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IL-17 | 38.0 | 54 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-17 | 32.0 | 63 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | IL-17 | 36.0 | 68 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-17 | 34.0 | 64 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | IL-17 | 31.0 | 57 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | IL-17 | 34.0 | 60 | ||||
RA2159 | 2 | IL-17 | 35.0 | 69 |